Related Experiment Video
Updated: Jul 29, 2026
08:22
Permanent Cerebral Vessel Occlusion via Double Ligature and Transection
Published on: July 21, 2013
14.9K
Middle Meningeal Artery Embolization for Subdural Hematoma
Huanwen Chen1, Marco Colasurdo2, Peter Kan3
1National Institutes of Neurological Disorders and Stroke, National Institutes of Health, 10 Center Drive, Bethesda, MD 20892, USA.
Neurosurgery Clinics of North America
|November 14, 2024
Summary
Chronic subdural hematoma (cSDH) is a common neurosurgical condition. Middle meningeal artery embolization (MMAE) shows promise in reducing cSDH recurrence after surgical evacuation.
Area of Science:
- Neurosurgery
- Vascular Interventional Radiology
Background:
- Chronic subdural hematoma (cSDH) is a prevalent neurosurgical condition with increasing global incidence.
- Current surgical evacuation for cSDH offers symptomatic relief but has high recurrence rates due to unaddressed pathophysiology.
- Middle meningeal artery embolization (MMAE) is emerging as a key intervention to mitigate cSDH recurrence.
Purpose of the Study:
- To review the current management strategies for cSDH.
- To discuss the evolving role and efficacy of MMAE as an adjunct therapy for cSDH.
- To identify unresolved questions and future research directions in cSDH management.
Main Methods:
- Systematic review of contemporary cSDH management literature.
- Analysis of randomized controlled trials evaluating MMAE in cSDH.
- Discussion of clinical evidence and expert consensus on MMAE for cSDH.
Main Results:
- MMAE has demonstrated significant efficacy in reducing recurrence rates when used adjunctively with surgical evacuation for cSDH.
- Multiple randomized controlled trials support the effectiveness of MMAE in improving outcomes for cSDH patients.
- Despite proven efficacy, optimal integration of MMAE into routine cSDH care protocols requires further clarification.
Conclusions:
- MMAE represents a significant advancement in reducing cSDH recurrence.
- Further research is needed to define the precise role and indications for MMAE in the standard treatment algorithm for cSDH.
- The integration of MMAE into neurosurgical practice holds promise for improving long-term patient outcomes in cSDH.
Related Concept Videos
01:17Hemorrhagic Stroke l: Introduction
A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
01:29Hemorrhagic Stroke ll: Pathophysiology
A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...